Risultati della ricerca - Gibson, C. Michael
- Mostra 1 - 20 risultati su 87
- Vai alla pagina seguente
-
1
Issues in the assessment of the safety and efficacy of tenecteplase (TNK‐tPA) di Gibson, C. Michael, Marble, Susan J.
Pubblicazione 2009testo -
2
SECURE PCI: how important can a subgroup analysis be? di Kerneis, Mathieu, Yee, Megan K., Gibson, C. Michael
Pubblicazione 2018testo -
3
-
4
-
5
Admission Hyperglycemia and Acute Myocardial Infarction: Outcomes and Potential Therapies for Diabetics and Nondiabetics di Chakrabarti, Anjan K., Singh, Priyamvada, Gopalakrishnan, Lakshmi, Kumar, Varun, Elizabeth Doherty, Meagan, Abueg, Cassandra, Wang, Weici, Gibson, C. Michael
Pubblicazione 2012testo -
6
Effect of azithromycin and hydroxychloroquine in patients hospitalized with COVID‐19: Network meta‐analysis of randomized controlled trials di Chi, Gerald, Memar Montazerin, Sahar, Lee, Jane J., Kazmi, Syed Hassan A., Shojaei, Fahimehalsadat, Fitzgerald, Clara, Gibson, C. Michael
Pubblicazione 2021testo -
7
-
8
Safety and Efficacy of Rivaroxaban When Added to Aspirin Monotherapy Among Stabilized Post‐Acute Coronary Syndrome Patients: A Pooled Analysis Study of ATLAS ACS‐TIMI 46 and ATLAS... di Gibson, William J., Gibson, C. Michael, Yee, Megan K., Korjian, Serge, Daaboul, Yazan, Plotnikov, Alexei N., Burton, Paul, Braunwald, Eugene
Pubblicazione 2019testo -
9
Pre-Hospital Antiplatelet Therapy for STEMI Patients Undergoing Primary Percutaneous Coronary Intervention: What We Know and What Lies Ahead di Fabris, Enrico, Korjian, Serge, Coller, Barry S., Ten Berg, Jurrien M., Granger, Christopher B., Gibson, C. Michael, van ’t Hof, Arnoud W. J.
Pubblicazione 2021testo -
10
Late gadolinium enhancement is compatible with advanced age in hypertrophic cardiomyopathy: implications for risk stratification of sudden death di Chan, Raymond H, Maron, Martin, Hong, Susie, Haas, Tammy S, Lesser, John, Gibson, C Michael, Manning, Warren J, Maron, Barry J, Appelbaum, Evan
Pubblicazione 2012testo -
11
Antithrombotic Agents for Secondary Prevention after Acute Coronary Syndromes: A Systematic Review and Network Meta-Analysis di Fanaroff, Alexander C, Hasselblad, Victor, Roe, Matthew T, Bhatt, Deepak L, James, Stefan K, Steg, Ph Gabriel, Gibson, C Michael, Ohman, E Magnus
Pubblicazione 2017testo -
12
-
13
The AngelMed Guardian(®) System in the Detection of Coronary Artery Occlusion: Current Perspectives di Kazmi, Syed Hassan Abbas, Datta, Sudarshana, Chi, Gerald, Nafee, Tarek, Yee, Megan, Kalia, Akshun, Sharfaei, Sadaf, Shojaei, Fahimehalsadat, Mirwais, Sabawoon, Gibson, C Michael
Pubblicazione 2020testo -
14
Worldwide differences of hospitalization for ST-segment elevation myocardial infarction during COVID-19: A systematic review and meta-analysis() di Sofi, Francesco, Dinu, Monica, Reboldi, GianPaolo, Stracci, Fabrizio, Pedretti, Roberto F.E., Valente, Serafina, Gensini, GianFranco, Gibson, C. Michael, Ambrosio, Giuseppe
Pubblicazione 2022testo -
15
Clinical Features, Use of Evidence‐Based Therapies, and Cardiovascular Outcomes Among Patients With Chronic Kidney Disease Following Non–ST‐Elevation Acute Coronary Syndrome di Rhee, June‐Wha, Wiviott, Stephen D., Scirica, Benjamin M., Gibson, C. Michael, Murphy, Sabina A., Bonaca, Marc P., Morrow, David A., Mega, Jessica L.
Pubblicazione 2014testo -
16
Flurpiridaz F 18 PET: Phase II Safety and Clinical Comparison with SPECT Myocardial Perfusion Imaging for Detection of Coronary Artery Disease di Berman, Daniel S., Maddahi, Jamshid, Tamarappoo, B. K., Czernin, Johannes, Taillefer, Raymond, Udelson, James E., Gibson, C. Michael, Devine, Marybeth, Lazewatsky, Joel, Bhat, Gajanan, Washburn, Dana
Pubblicazione 2012testo -
17
Clinical Implications and Correlates of Q Waves in Patients With ST‐Elevation Myocardial Infarction Treated With Fibrinolysis: Observations from the CLARITY‐TIMI 28 Trial di Waks, Jonathan W., Sabatine, Marc S., Cannon, Christopher P., Morrow, David A., Gibson, C. Michael, Wiviott, Stephen D., Giugliano, Robert P., Sloan, Sarah, Scirica, Benjamin M.
Pubblicazione 2014testo -
18
Safety and Efficacy of Double Antithrombotic Therapy With Non–Vitamin K Antagonist Oral Anticoagulants in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Interve... di Capodanno, Davide, Di Maio, Marco, Greco, Antonio, Bhatt, Deepak L., Gibson, C. Michael, Goette, Andreas, Lopes, Renato D., Mehran, Roxana, Vranckx, Pascal, Angiolillo, Dominick J.
Pubblicazione 2020testo -
19
Relationship between ST-segment resolution and anterior infarct size after primary percutaneous coronary intervention: analysis from the INFUSE-AMI trial di Dizon, José M, Brener, Sorin J, Maehara, Akiko, Witzenbichler, Bernard, Biviano, Angelo, Godlewski, Jacek, Parise, Helen, Dambrink, Jan-Henk, Mehran, Roxana, Gibson, C Michael, Stone, Gregg W
Pubblicazione 2014testo -
20
Early Dynamic Risk Stratification with Baseline Troponin Levels and 90-minute ST Segment Resolution to Predict 30 Day Cardiovascular Mortality in STEMI: Analysis from CLARITY TIMI-... di Sherwood, Matthew W., Morrow, David A., Scirica, Benjamin M., Jiang, Songtao, Bode, Christoph, Rifai, Nader, Gerszten, Robert E., Gibson, C. Michael, Cannon, Christopher P., Braunwald, Eugene, Sabatine, Marc S.
Pubblicazione 2010testo